Risk
10 Predictions for 2024, in Memory of Byron Wien
JPM’s Cembalest gives prophecy a try in a tribute to the late market sage.
JPM’s Cembalest gives prophecy a try in a tribute to the late market sage.
The proposed disclosure rules in the White House’s antitrust push could make filing for deals more difficult, critics argue.
Legal action could influence whether the European Commission approves the $30 billion acquisition.